These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23261493)

  • 41. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo.
    Berk M; Turner A; Malhi GS; Ng CH; Cotton SM; Dodd S; Samuni Y; Tanious M; McAulay C; Dowling N; Sarris J; Owen L; Waterdrinker A; Smith D; Dean OM
    BMC Med; 2019 Jan; 17(1):18. PubMed ID: 30678686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Brooks DJ; Pavlicova M; Cheng W; Nunes EV
    Drug Alcohol Depend; 2011 Jul; 116(1-3):142-50. PubMed ID: 21310551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of marijuana use on neurocognitive functioning in adolescents.
    Schweinsburg AD; Brown SA; Tapert SF
    Curr Drug Abuse Rev; 2008 Jan; 1(1):99-111. PubMed ID: 19630709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals.
    McRae-Clark AL; Carter RE; Price KL; Baker NL; Thomas S; Saladin ME; Giarla K; Nicholas K; Brady KT
    Psychopharmacology (Berl); 2011 Nov; 218(1):49-58. PubMed ID: 21710170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cue reactivity in young marijuana smokers: a preliminary investigation.
    Gray KM; LaRowe SD; Upadhyaya HP
    Psychol Addict Behav; 2008 Dec; 22(4):582-6. PubMed ID: 19071985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
    Cooper ZD; Haney M
    Addict Biol; 2008 Jun; 13(2):188-95. PubMed ID: 18279497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Marijuana withdrawal in humans: effects of oral THC or divalproex.
    Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
    Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of treatment for nicotine dependence on alcohol and drug treatment outcomes.
    Joseph AM; Nichol KL; Anderson H
    Addict Behav; 1993; 18(6):635-44. PubMed ID: 8178702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marijuana commercialization and adolescent substance treatment outcomes in Colorado.
    LeNoue SR; Salomonsen-Sautel S; Min SJ; Thurstone C
    Am J Addict; 2017 Dec; 26(8):802-806. PubMed ID: 29064160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study.
    Sigmon SC; Steingard S; Badger GJ; Anthony SL; Higgins ST
    Exp Clin Psychopharmacol; 2000 Nov; 8(4):509-17. PubMed ID: 11127422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Engaging young probation-referred marijuana-abusing individuals in treatment: a pilot trial.
    Sinha R; Easton C; Renee-Aubin L; Carroll KM
    Am J Addict; 2003; 12(4):314-23. PubMed ID: 14504024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Assistance for the treatment of cravings on smartphones].
    Lucet C; Dupouy J; Rousselet AV; Caron M; Polin R; Laqueille X
    Soins Psychiatr; 2017; 38(311):37-39. PubMed ID: 28683885
    [No Abstract]   [Full Text] [Related]  

  • 54. Use of dronabinol for cannabis dependence: two case reports and review.
    Levin FR; Kleber HD
    Am J Addict; 2008; 17(2):161-4. PubMed ID: 18393061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A marijuana smoking cessation clinical trial utilizing THC-free marijuana, aversion therapy, and self-management counseling.
    Smith JW; Schmeling G; Knowles PL
    J Subst Abuse Treat; 1988; 5(2):89-98. PubMed ID: 2839683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Why don't they stop? Understanding unplanned marijuana use among adolescents and young adults.
    Emery NN; Carpenter RW; Treloar Padovano H; Miranda R
    Psychol Addict Behav; 2020 Aug; 34(5):579-589. PubMed ID: 32039620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intensive therapy: utilizing hypnosis in the treatment of substance abuse disorders.
    Potter G
    Am J Clin Hypn; 2004 Jul; 47(1):21-8. PubMed ID: 15376606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias.
    Metrik J; Aston ER; Kahler CW; Rohsenow DJ; McGeary JE; Knopik VS; MacKillop J
    Drug Alcohol Depend; 2016 Oct; 167():82-8. PubMed ID: 27515723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence.
    Hanson KL; Winward JL; Schweinsburg AD; Medina KL; Brown SA; Tapert SF
    Addict Behav; 2010 Nov; 35(11):970-6. PubMed ID: 20621421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cannabis withdrawal in adolescent treatment seekers.
    Vandrey R; Budney AJ; Kamon JL; Stanger C
    Drug Alcohol Depend; 2005 May; 78(2):205-10. PubMed ID: 15845324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.